Press release
Specificity Inc. (OTCID: SPTY) AI-Powered Technology Poised to Disrupt the Media Sector - More Stocks Inside
Key Differentiators:
* Verified Human Targeting - No bots. No fraud. Just real people.
* Cross-Platform Continuity - One audience across display, social, and video.
* Real-Time AI-Driven Data - Daily intent signals for peak performance.
In addition to Specificity Inc. (OTCID: SPTY)keep an eye on these high-momentum disruptors: DURECT Corp (NASDAQ: DRRX), Calidi Biotherapeutics Inc. (NYSE: CLDI), fuboTV Inc. (NYSE: FUBO), Healthcare Triangle Inc. (NASDAQ: HCTI), Safe and Green (NASDAQ: SGD), Salarius Pharma Inc. (NASDAQ: SLRX), ESGold Corp (CSE: ESAU | OTCQB: ESAUF), Defense Technologies (OTCID: DTII), Pineapple Express (OTCID: PNXP) and Element79 Gold (CSE: ELEM | OTCQB: ELMGF) as they are moving aggressively in Trading today-worth watching closely.
Closing the Loop on Cross-Channel Precision
Specificity has cracked the code on true omnichannel targeting-serving video ads to the same audiences already reached via display and social. This creates consistent, high-impact engagement powered by real-time AI intent data.
"We're targeting the same real humans-display, social, and video. That's true omnichannel precision," said CEO Jason Wood. By owning the audience-not the platform, Specificity delivers aligned messaging, eliminates waste, and drives superior campaign results.
Strategic Partnership with Blackpearl Group
In a move to further elevate its clean-data strategy, Specificity has partnered with Blackpearl Group (BPG.NZ [http://bpg.nz/]), developers of Pearl Diver , an AI-powered intent data platform. This collaboration enhances Specificity's real-time consumer targeting with deeper, more accurate insights-solidifying its position as a leader in AI media technology. With a fully restored SEC status, growing strategic alliances, and a tech stack built for real people, Specificity Inc. (OTCID: SPTY) is redefining digital marketing-and leading the next wave of ad tech innovation.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=specificity-inc-otcid-spty-aipowered-technology-poised-to-disrupt-the-media-sector-more-stocks-inside]
Country: United States
Website: http://www.thestreetreports.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Specificity Inc. (OTCID: SPTY) AI-Powered Technology Poised to Disrupt the Media Sector - More Stocks Inside here
News-ID: 4125236 • Views: …
More Releases from ABNewswire
Freelance Platforms Market Forecast to Reach USD 16.54 Billion by 2030, Driven b …
Mordor Intelligence has published a new report on the Freelance Platforms Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Freelance Platforms Market Outlook
The freelance platforms market size [https://www.mordorintelligence.com/industry-reports/freelance-platforms-market?utm_source=abnewswire] stands at USD 7.65 billion in 2025 and is forecast to reach USD 16.54 billion by 2030, advancing at a 16.66% CAGR. The Freelance Platforms Market share is currently dominated by platform models, while services are gaining momentum with…
Surprising Comparison: Disney vs. Taylor Swift Concert Costs
Disney World Ticket Prices Nearly Double Over Past Decade: PixieVacations Reveals Comprehensive Analysis and Money-Saving Strategies for 2025 Travelers
Walt Disney World ticket prices reach historic highs in 2025, with peak one-day Magic Kingdom tickets now exceeding $200 for the first time ever, PixieVacations.com has released a comprehensive analysis of Disney World ticket prices over the past decade. The leading Disney vacation planning service aims to help families navigate these rising…
Medicus Pharma (Nasdaq: MDCX) Nears Surgery-Free Breakthrough in Oncology
Skin cancer is rarely viewed as life-changing, but for millions of patients each year, basal cell carcinoma brings a cycle of surgeries, scars, and slow recovery that feels endless. Hospitals are overloaded, dermatologists are booked months in advance, and treatments that remove tumors often leave lasting damage. The challenge is not identifying the cancer; it is finding a way to treat it without cutting the patient open. That is the…
Adapts.ai Redefines Software Maintenance and Modernization with GenAI-Powered Pl …
October 10, 2025 - In an era where digital transformation defines competitive advantage, Adapts.ai is emerging as a game-changer in enterprise application modernization and AI-driven digital transformation services. The platform leverages next-generation GenAI technology to simplify software maintenance, accelerate legacy code modernization, and empower engineering teams with intelligent automation.
Adapts addresses one of the most pressing challenges in modern software engineering - navigating outdated, poorly documented, and complex legacy codebases. Traditional…
More Releases for Specificity
TCR Therapy Pipeline Insight 2025: Targeting Intracellular Tumor Antigens with U …
T-cell receptor (TCR) therapy represents a next-generation cell-based immunotherapy that unlocks access to intracellular tumor antigens presented via MHC molecules, overcoming limitations of conventional CAR-T therapies. TCR therapies are gaining momentum, particularly for solid tumors, by enabling antigen-specific immune responses that are tailored to a patient's unique HLA profile. DelveInsight's "TCR Therapy - Pipeline Insight, 2025" analyzes over 55 pipeline candidates under active clinical development, focusing on high-value targets such…
Engineering Multivalent Antibodies for Specificity and Potency
The engineering of multivalent antibodies represents a cutting-edge approach in the development of highly specific and potent therapeutics. These antibodies, designed to bind multiple antigens or epitopes simultaneously, offer significant advantages over traditional monoclonal antibodies, providing enhanced efficacy and reducing the likelihood of resistance. The focus on specificity and potency in multivalent antibody design opens new avenues for treating complex diseases, particularly in oncology, infectious diseases, and autoimmune disorders.
Download Bispecific,…
Global Dual Specificity Protein Kinase TTK Market Forecast 2019-2026
Global Dual Specificity Protein Kinase TTK Market: Overview
The Global Dual Specificity Protein Kinase TTK Market is one of the fastest growing markets nowadays. It has shown good growth in previous few years. The global Dual Specificity Protein Kinase TTK market is anticipated to show more growth in the future. Dual Specificity Protein Kinase TTK market report provides you depth knowledge about the Dual Specificity Protein Kinase TTK market studies findings…
Product Specificity Analysis: Upgradation in Lifestyles of Individuals Through P …
Developments in modern societies encourage a focus on the needs and goals of the individual. Product Specificity is a counter-trend amid the near-ubiquitous mass-market products and brands, and consumers are looking for more bespoke, personalized products and services. Designing these products and services is beneficial for both consumers and manufacturers, leading to higher consumer satisfaction and product/brand loyalty.
Product Specificity is one of the 63 trends that has been covered as…
Tyrosine Kinase Inhibitors Market: Specificity and Efficacy to Boost Adoption
Cancer is the unregulated growth of body cells due to genetic mutations in its differentiation regulatory genes. Tyrosine kinases are enzymes that signal the cell differentiation cycle, mutation in their expression genes leads to their over expression, which results in uncontrolled proliferation of cells to form tumors. To comprehend recent trends, factors that are influencing growth of global tyrosine kinase inhibitors market, Market Research Hub (MRH) has included a report…
Trend Sights Analysis: Product Specificity Addressing The Consumer Need To Share …
Summary
A counter-trend amid the ubiquity of mass-market products and brands is the search for more bespoke, personalized products and services. "Mass customization" is being adopted as consumer-facing companies seek to capitalize on demand for greater product variety and individualization. Products that meet more personal needs are perceived as offering superior value.
Key Findings
"Just-for-me" product solutions appeal to today's self-expressive and individualistic consumers who reject a "one-size-fits-all" approach to consumption/usage of products.…
